Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions
PHASE1CompletedINTERVENTIONAL
Enrollment
58
Participants
Timeline
Start Date
July 31, 2007
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Conditions
Healthy
Interventions
DRUG
verapamil controlled release
verapamil 300 mg controlled release capsule as a single dose
All Listed Sponsors
lead
Synerx Pharma, LLC
INDUSTRY
NCT01467687 - Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter